Evidence map›Paper›PMID 38654214›Full record

ArticleBMC ophthalmology2024

Effect of intravitreal injections due to neovascular age-related macular degeneration on retinal nerve fiber layer thickness and minimum rim width: a cross sectional study.

Agnes Boltz, Tanja Spöttl, Wolfgang Huf, Birgit Weingessel, Veronika Pia Vécsei-Marlovits

Open access · goldAbstract read
In one paragraph

Article in BMC ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Agnes BoltzDepartment of Ophthalmology, Hietzing Hospital, Wolkersbergenstraße 1, Vienna, 1130, Austria. agnes.boltz@gesundheitsverbund.at.
Tanja SpöttlDepartment of Ophthalmology, Hietzing Hospital, Wolkersbergenstraße 1, Vienna, 1130, Austria.
Wolfgang HufDepartment of Laboratory Medicine, Hietzing Hospital, Vienna, Austria.
Birgit WeingesselDepartment of Ophthalmology, Hietzing Hospital, Wolkersbergenstraße 1, Vienna, 1130, Austria.
Veronika Pia Vécsei-MarlovitsDepartment of Ophthalmology, Hietzing Hospital, Wolkersbergenstraße 1, Vienna, 1130, Austria.
Karl Landsteiner Society · ATKlinik Hietzing · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe present study tested the hypothesis that repeated anti-VEGF injections are associated with reduced retinal nerve fiber layer (RNFL) and minimum rim width (MRW) of the optic nerve head. PATIENTS AND

methodsSixty-six patients with a history of intravitreal injections due to neovascular age-related macular degeneration were included. RNFL and MRW were measured using optical coherence tomography (Spectralis OCT, Heidelberg Engineering, Heidelberg, Germany).

resultsMean global RNFL was 90.62 μm and both RNFL as well as MRW significantly decreased with advanced age (p = 0.005 and p = 0.019, respectively). Correlating for the number of injections, no significant impact on RNFL was found globally (p = 0.642) or in any of the sectors. In contrast, however, global MRW was significantly reduced with increasing numbers of intravitreal injections (p = 0.012). The same holds true when adjusted for the confounding factor age (RNFL p = 0.566 and MRW p = 0.023).

conclusionOur study shows that repeated intravitreal injections due to choroidal neovascularization seem to have a deleterious effect on MRW but not on RNFL. This suggests that MRW is a more sensitive marker than RNFL for evaluating the effect of frequent intravitreal injections on the optic nerve head since it seems to be the first structure affected.

Indexed as

Angiogenesis InhibitorsIntravitreal InjectionsNerve FibersRetinal Ganglion CellsTomography, Optical CoherenceAgedAged, 80 and overBevacizumabCross-Sectional StudiesFemaleHumansMaleMiddle AgedOptic DiskRanibizumabVascular Endothelial Growth Factor AAngiogenesis InhibitorsBevacizumabRanibizumabVascular Endothelial Growth Factor AAnti-VEGFCNVIntravitreal injectionsMinimum rim widthRetinal nerve fiber layer thickness

Identifiers

PMID38654214
PMCPMC11036677
OpenAlexW4395048125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.